Patent · US Active

Genetically modified non-human animal with human or chimeric CD3e

US10945420B2 · kind B2 · utility

1Cited by

1References

18Claims

0Family size

Assignees

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN
Biocytogen JiangSu Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Yanan Guo · Beijing, CN
Rui Huang · Beijing, CN
Xiaofei Zhou · Beijing, CN
Yang Bai · Beijing, CN
Jiawei Yao · Beijing, CN
Chaoshe Guo · Beijing, CN

Key dates

Filing date	Jun 10, 2019
Grant date	Mar 16, 2021
Priority date	—
Expiry date	Jun 10, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA01K2267/0387
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD3e (T-cell surface glycoprotein CD3 epsilon chain), and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.